246 related articles for article (PubMed ID: 9401321)
1. Pemoline in ADHD.
Winsberg B; Barbato M
J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
[No Abstract] [Full Text] [Related]
2. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Marcus SC; Durkin M
J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):480-9. PubMed ID: 21515197
[TBL] [Abstract][Full Text] [Related]
3. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
4. OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.
Marchant BK; Reimherr FW; Halls C; Williams ED; Strong RE
Ann Clin Psychiatry; 2010 Aug; 22(3):196-204. PubMed ID: 20680193
[TBL] [Abstract][Full Text] [Related]
5. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
6. Coming into focus. Pharmacologic treatment for ADHD.
McDonnell MA; Moffett C
Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
[No Abstract] [Full Text] [Related]
7. Pemoline (Cylert): market withdrawal.
Hogan V
CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
[No Abstract] [Full Text] [Related]
8. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Developments in treatment.
Levy F
Aust N Z J Psychiatry; 2002 Aug; 36(4):477-9. PubMed ID: 12169142
[No Abstract] [Full Text] [Related]
9. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
Pelham WE; Swanson JM; Furman MB; Schwindt H
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
[TBL] [Abstract][Full Text] [Related]
10. An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
Riggs PD; Thompson LL; Mikulich SK; Whitmore EA; Crowley TJ
J Am Acad Child Adolesc Psychiatry; 1996 Aug; 35(8):1018-24. PubMed ID: 8755798
[TBL] [Abstract][Full Text] [Related]
11. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
Rao JK; Julius JR; Breen TJ; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
[TBL] [Abstract][Full Text] [Related]
12. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse.
Heiligenstein E; Anders J
J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682
[TBL] [Abstract][Full Text] [Related]
13. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
DelBello MP
J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
[No Abstract] [Full Text] [Related]
14. [Attention deficit hyperactivity disorder in children].
Bervoets L
J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
[No Abstract] [Full Text] [Related]
15. Photic responses in "minimal brain dysfunction".
Milstein V; Small JG
Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
[No Abstract] [Full Text] [Related]
16. Compliance with FDA recommendations for pemoline.
Sarkis EH
J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383; author reply 383. PubMed ID: 12649623
[No Abstract] [Full Text] [Related]
17. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
Spencer T; Biederman J; Wilens T
Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
[TBL] [Abstract][Full Text] [Related]
18. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
Conners CK
Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
[No Abstract] [Full Text] [Related]
19. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
[TBL] [Abstract][Full Text] [Related]
20. A rare case of dependence on pemoline.
Bonnet U; Davids E
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]